Surgical strategies for unresectable hepatoblastomas

Journal of Pediatric Surgery

Volumn 47, Issue 12, 2012, Pages 2194-2198

  Tajiri, Tatsuro ^a,b   Kimura, Osamu ^a   Fumino, Shigehisa ^a   Furukawa, Taizo ^a   Iehara, Tomoko ^a   Souzaki, Ryota ^c   Kinoshita, Yoshiaki ^c   Koga, Yuhki ^c   Suminoe, Aiko ^c   Hara, Toshiro ^c   Kohashi, Kenichi ^c   Oda, Yoshinao ^c   Hishiki, Tomoro ^b   Hosoi, Hajime ^a   Hiyama, Eiso ^b   Taguchi, Tomoaki ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Japanese Study Group for Pediatric Liver Tumor (JPLT)   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatoblastoma; Liver resection; Liver transplantation; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PIRARUBICIN;

BILE LEAKAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFERENCE PAPER; FEMALE; HEPATOBLASTOMA; HUMAN; INCIDENCE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER VEIN; LOBECTOMY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE CARE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84870676211     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2012.09.006     Document Type: Conference Paper

References (10)

1. S. Suita, T. Tajiri, and H. Takamatsu Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen. A report from the study group for pediatric solid malignant tumors in the Kyushu area, Japan J Pediatr Surg 39 2004 195 198
2. J.A. Ortega, E.C. Douglass, and J.H. Feusner Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/ continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group J Clin Oncol 18 2000 2665 2675
3. F. Sasaki, T. Matsunaga, and M. Iwafuchi Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor J Pediatr Surg 37 2002 851 856
4. T. Hishiki, T. Mtasunaga, and F. Sasaki Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from JPLT Pediatr Surg Int 27 2010 1 8
5. M. Browne, D. Sher, and D. Grant Survival after liver transplantation for hepatoblastoma: a 2-center experience J Pediatr Surg 43 2008 1973 1981
6. W. Faraj, F. Dar, and G. Marangoni Liver transplantation for hepatoblastoma Liver Transpl 14 2008 1614 1619
7. J.B. Otte, J. de Ville de Goyet, and R. Reding Liver transplantation for hepatoblastoma: indications and contraindications in the modern era Pediatr Transplant 9 2005 557 565
8. T.B. Lautz, T. Ben-Ami, and N. Tantemsapya Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma Cancer 117 2011 1976 1983
9. D.J. Roebuck, D. Aronson, and P. Clapuyt 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group Pediatr Radiol 37 2007 123 132
10. J. Brown, G. Perilongo, and E. Shafford Pretreatment prognostic factors for children with hepatoblatoma - results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1 Eur J Cancer 36 2000 1418 1425